NuVision Biotherapies
Develops innovative ophthalmic therapies
NuVision Biotherapies has raised €7.3M across 3 funding rounds from 8 investors, most recently a round in Feb 2026. Based in Nottingham, UK; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€7.3M
€7,303,292
Funding rounds
3
Investors
8
distinct backers
Active since
2015-07
latest 2026-02
Funding by year
EUR raised per year · 2026 YTDNuVision Biotherapies — funding by year — interactive chart.
Data table
| NuVision Biotherapies — funding by year | |
|---|---|
| 2015 | €534k |
| 2023 | €1.2M |
| 2026 | €5.5M |
Signals
High confidenceRaise-next likelihood36
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
- ▲ 11y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-06 | Other | €5.5M | Mercia Ventures,Midlands Engine Investment Fund II,Pioneer Fund,University of Nottingham | View deal → |
| 2023-03-09 | Other | €1.2M | MEIF Proof of Concept & Early Stage Fund,Mercia’s EIS Funds,Midlands Engine Investment Fund,Pioneer Fund,University of Nottingham | View deal → |
| 2015-07-01 | Seed | €534k | Mercia Ventures | View deal → |
Investors
8Related news
- NuVision Raises Further £1.1M in Fundingfinsmes.com · 2023-03
- techcitynews.com
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData